Lisa Shafer

Lisa Shafer

Company: Cerebral Therapeutics

Job title: Chief Scientific Officer


Panel Discussion: Business Development Perspectives on the Oligonucleotides Space 2:30 pm

Exploring historical trends in business development and financing for oligonucleotide therapeutics Uncovering the challenges and opportunities these trends present for those attempting to innovate within this disease area Explaining what investors need to see in order to invest Perspectives on the need to demonstrate both mechanistic understanding and a regulatory pathway through to the marketRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.